|
How to Cite 1. For In-Text Citation (Materials & Methods): 2. For Key Resources Table: |
||
|
Toll Free: (877) 796-6397 -- USA and Canada only -- |
Fax: +1-832-582-8590 Orders: +1-832-582-8158 |
Tech Support: +1-832-582-8158 Ext:3 Please provide your Order Number in the email. We strive to reply to |
Anti-mouse PD-1 (CD279)-InVivo
Catalog No.A2122 Batch: A212227
Clone No.RMP1-14
Anti-mouse PD-1 (CD279)-InVivo(Clone:RMP1-14) reacts with mouse PD-1 (programmed death-1) also known as CD279. PD-1 is a 50-55 kDa cell surface receptor encoded by the Pdcd1 gene that belongs to the CD28 family of the Ig superfamily.
Technical Data
| Formulation | PBS Buffer, PH 7.4 |
|---|---|
| Clone | RMP1-14 |
| Isotype | Rat IgG2a, κ |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C and avoid freeze-thaw cycle |
| Sterility | 6.06 mg/mL |
| Purity | 99% |
| Protein concentration | 6.06 mg/mL |
| Endotoxin Level | ＜1 EU/mg |
Customer Product Validation
-InVivo.gif)
Selleck's Anti-mouse PD-1 (CD279)-InVivo Has Been Cited by 26 publications
| Differential expression pattern of CC chemokine receptor 7 guides precision treatment of hepatocellular carcinoma [ Signal Transduct Target Ther, 2025, 10(1):229] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40685403 |
| Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma [ Signal Transduct Target Ther, 2025, 10(1):82] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40032871 |
| Massively parallel interrogation of human functional variants modulating cancer immunosurveillance [ Signal Transduct Target Ther, 2025, 10(1):88] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40102418 |
| Nanosized Shikonin Disrupts Tumor-Cell Mismatch Repair and Synergizes with Manganese to Sensitize Squamous Carcinoma to Immunotherapy [ ACS Nano, 2025, 19(14):13889-13905] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40190094 |
| The mechanism of YAP/TAZ transactivation and dual targeting for cancer therapy [ Nat Commun, 2025, 16(1):3855] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40274828 |
| A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy [ Research (Wash D C), 2025, 8:0735] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40530387 |
| Targeting HK3 in tumor-associated macrophages enhances antitumor immunity through augmenting antigen cross-presentation in cervical cancer [ J Immunother Cancer, 2025, 13(7)e011948] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40664447 |
| Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma [ J Immunother Cancer, 2025, 13(12)e012982] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=41365532 |
| USP15 Facilitates Colorectal Cancer Immune Evasion through SMYD3/CCL2-Dependent Myeloid-Derived Suppressor Cell Recruitment [ Cancer Immunol Res, 2025, 10.1158/2326-6066.CIR-24-1194] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=40323348 |
| FAM135B Deficiency Inhibits Cytotoxic T-Cell Activity in Triple-negative Breast Cancer by Blocking the IFI16-dependent STING Pathway [ Cancer Immunol Res, 2025, 10.1158/2326-6066.CIR-25-0310] |
https://www.ncbi.nlm.nih.gov/pubmed/?term=41218197 |
FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.
Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.